Basel, Switzerland

Bernhard Reis

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Bernhard Reis in Cancer Therapy

Introduction

Bernhard Reis, a notable inventor based in Basel, Switzerland, has made significant strides in the field of cancer treatment. With one patent to his name, he has focused his research on the development of GPC3-targeting drugs, aimed at enhancing the efficacy of cancer therapies. His work stands at the intersection of innovation and healthcare, showcasing the importance of targeted treatments in modern medicine.

Latest Patents

Reis' patent pertains to a method for determining the efficacy of GPC3-targeting drug therapy in cancer patients. This method involves assessing the presence and levels of specific immunocytes or molecules expressed on these immunocytes in biological samples taken from patients. The determination of a predetermined value for either the number of immunocytes or the expression level of the target molecule serves as a basis for evaluating the effectiveness of the GPC3-targeting therapy. This innovative approach not only helps in deciding the commencement of treatment but also provides insights into the continuation of therapy during patient care.

Career Highlights

Throughout his career, Bernhard Reis has been associated with prominent companies, including Chugai Pharmaceutical Co., Ltd. and F. Hoffmann-La Roche AG. His experience in these leading pharmaceutical firms has provided him with a robust platform to develop his groundbreaking ideas and contribute to advancements in cancer treatment.

Collaborations

Reis has worked alongside esteemed colleagues such as Toshihiko Ohtomo and Takayoshi Tanaka. These collaborations have substantially enriched his research endeavors and fostered a collaborative environment for innovative thinking, which is crucial in the fast-evolving field of medical research.

Conclusion

Bernhard Reis is a pivotal figure in the realm of cancer treatment innovation. His patented method for evaluating GPC3-targeting drug therapy underscores the significance of precision medicine in enhancing treatment outcomes. As research continues in this area, Reis' contributions will undoubtedly leave a lasting impact on how cancer therapies are approached and administered, paving the way for more personalized and effective treatment strategies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…